BackTelesis Bio Overview

Telesis Bio Current Cash

Latest current cash for TBIO: $3.7M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.72M
↓ 78.61% YoYΔ $-13.68M vs prior year quarter

Peer trimmed avg / median

Loading

Telesis Bio Current Cash History

Loading

Telesis Bio vs. peers: Current Cash Comparison

Loading

Telesis Bio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Telesis Bio (TBIO) FAQ

Telesis Bio (TBIO) currently reports a current cash of $3.7M as of September 2024. That compares with $17M in the prior-year period — down 78.6% year over year. Use the charts on this page to explore Telesis Bio's current cash history and peer comparisons.

Telesis Bio's current cash decreased from $17M to $3.7M — a 78.6% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telesis Bio reported $3.7M in current cash as of September 2024. That compares with $17M in the prior-year period — down 78.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telesis Bio, and consider following TBIO for alerts when major investors trade the stock.

Telesis Bio is classified in the Healthcare sector. On current cash, it currently shows $3.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TBIO with unrelated industries.